OneMedNet Corporation (NASDAQ:ONMD – Get Free Report) shares crossed below its 50-day moving average during trading on Wednesday. The stock has a 50-day moving average of $5.41 and traded as low as $5.31. OneMedNet shares last traded at $5.37, with a volume of 12,165 shares trading hands.
Wall Street Analyst Weigh In
Separately, Weiss Ratings upgraded OneMedNet from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, August 24th. One equities research analyst has rated the stock with a Sell rating. According to MarketBeat.com, the stock currently has a consensus rating of “Sell”.
View Our Latest Stock Report on OneMedNet
OneMedNet Stock Performance
Insider Activity
In other news, insider Jeffrey Yu bought 45,126 shares of the firm’s stock in a transaction that occurred on Friday, October 9th. The stock was purchased at an average cost of $5.54 per share, with a total value of $249,998.04. Following the transaction, the insider directly owned 896,840 shares in the company, valued at $4,968,493.60. This trade represents a 5.30% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Thomas Kosasa bought 129,758 shares of the stock in a transaction dated Wednesday, October 7th. The shares were acquired at an average price of $5.78 per share, for a total transaction of $750,001.24. Following the completion of the transaction, the director owned 1,983,573 shares of the company’s stock, valued at approximately $11,465,051.94. The trade was a 7.00% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. In the last three months, insiders bought 189,169 shares of company stock valued at $1,089,995 and sold 15,167 shares valued at $103,042. Company insiders own 50.20% of the company’s stock.
About OneMedNet
OneMedNet Corporation (NASDAQ: ONMD) is a healthcare technology company focused on improving the access, exchange and use of medical imaging data. Its platform is designed to connect healthcare organizations, researchers, life sciences companies and other authorized users with clinical imaging datasets while supporting data privacy, security and governance requirements. OneMedNet’s technology uses a decentralized approach in which medical data can remain with the organization that originally collected it, rather than being transferred to a central repository.
See Also
- Five stocks we like better than OneMedNet
- Nu Holdings Earnings Show a Compounder Priced Like a Brazil Bet
- Game On: The Hidden Value in Take-Two’s Stock
- LightPath Technologies’ Record Backlog Highlights a Bigger Defense Opportunity
- A 10-Stock Strategy That Balances AI Growth With Cash Flow
Receive News & Ratings for OneMedNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OneMedNet and related companies with MarketBeat.com's FREE daily email newsletter.
